BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• BioCapital

  Emmes Will Support Development of a New Universal Flu Vaccine for The National Institute of Allergy and Infectious Diseases

  The Company’s Contract with Digital Infuzion Adds New Dimension to its Long NIAID History

  December 2, 2019

   · 

  3 min read
• Business

  Indivumed Announces Strategic Partnership with Biognosys

  Partnership Aims to Enhance Proteomics and Phosphoproteomics Insights in the IndivuType Multi-Omics Cancer Database

  December 2, 2019

   · 

  4 min read
• Business

  Phathom Pharmaceuticals Expands Leadership Team and Announces Board Transition

  Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, announced today multiple executive appointments.

  December 2, 2019

   · 

  6 min read
• Drug Development

  Phathom Pharmaceuticals Announces Initiation of Pivotal Phase 3 Clinical Trial for Vonoprazan in Erosive Esophagitis

  PHALCON-EE is a randomized, double-blind, two-phase, multicenter Phase 3 trial that is planned to enroll approximately 1,000 patients with EE in the U.S. and Europe.

  December 2, 2019

   · 

  5 min read
• Biotech Bay

  ORIC Pharmaceuticals to Present at the 31st Annual Piper Jaffray Healthcare Conference

  ORIC Pharmaceuticals is a privately held, clinical-stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance

  December 2, 2019

   · 

  1 min read
• Business

  Metastatic Breast Cancer Alliance Announces Release of MBC Connect 2.0

  National Nonprofit’s Updated Mobile App and Online Platform will Identify Potential Clinical Trial Matches for Patients

  December 2, 2019

   · 

  3 min read
• Drug Development

  Rafael Pharmaceuticals Announces Expansion of Phase 2 Trial of CPI-613® (devimistat) for Patients with Relapsed or Refractory Burkitt’s Lymphoma/Leukemia to Massachusetts General Hospital in Boston

  The trial is currently underway at Memorial Sloan Kettering Cancer Center in New York City and at City of Hope in Duarte, California.

  December 2, 2019

   · 

  4 min read
• Pharm Country

  Dr. David Samadi of RoboticOncology discusses why eating more mushrooms may reduce risk of prostate cancer

  This news is from a long-term cohort study of more than 36,000 Japanese men over 13 years suggesting an association between eating mushrooms and a lower risk of prostate cancer.

  December 2, 2019

   · 

  2 min read
• Business

  First Of Its Kind Memory Disorder Prison Unit: Federal Inmates Certified As Certified Nursing Assistants, Federal Correctional Staff Certified With Specialized Certification

  The National Council of Certified Dementia Practitioners (NCCDP) credential enables inmate staff with the knowledge and tools necessary to respond to cognitively impaired inmates

  December 2, 2019

   · 

  7 min read
• LabTwin’s CEO Wins 16th Annual STEVIE® Award for Women in Business and LabTwin Wins Gold for Best New Product or Service of the Year

  Magdalena Paluch wins Gold as Female Entrepreneur of the Year in Europe, the Middle East & Africa, and Silver Award for Most Innovative Woman of the Year - Technology, while LabTwin wins Gold for Best New Product or Service of the Year

  December 2, 2019

   · 

  4 min read